Comparing GLP-1 Receptor Agonists with SGLT2 Inhibitors for Type 2 Diabetes Patients
April 12, 202017m 27s
Audio is streamed directly from the publisher (audioboom.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Investigators from Saint Louis University discuss their recent study comparing GLP-1 receptor agonists with SGLT2 inhibitors.